Drug intelligence / Profile preview

TZ-POR 7e

Development stage
Preclinical
Lead developer
Massachusetts General Hospital
Modality
Small Molecules
Administration
Intravenous
01

Overview

TZ-POR 7e is a tetrazine-functionalized porphyrin derivative designed for use in pretargeted photodynamic therapy (PT-PDT). It serves as a bioorthogonal photosensitizer that utilizes the inverse electron-demand Diels-Alder (IEDDA) reaction to covalently 'click' onto trans-cyclooctene (TCO)-modified targeting vectors, such as monoclonal antibodies, that have been previously localized at a tumor site. This pretargeting strategy is intended to enhance the therapeutic window of photodynamic therapy by allowing the photosensitizer to accumulate specifically at the target tissue while clearing from systemic circulation, thereby reducing off-target phototoxicity. Once localized and activated by light of a specific wavelength (typically in the red or near-infrared spectrum), the porphyrin core of TZ-POR 7e acts as a catalyst to transfer energy to molecular oxygen, generating highly cytotoxic singlet oxygen and other reactive oxygen species (ROS). These species induce localized oxidative damage, leading to tumor cell apoptosis, necrosis, and vascular shutdown.

Other names
Tetrazine-porphyrin 7eTetrazine-porphyrin7eTetrazine-porphyrin-7eTZ-POR

Beyond the preview

Go deeper on TZ-POR 7e.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TZ-POR 7e.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call